New C-2 symmetrical and semisymmetrical substituted imidazolium ribonucleoside. Imidazolic nucleosides analogues

被引:11
作者
AlMourabit, A
Beckmann, M
Poupat, C
Ahond, A
Potier, P
机构
[1] Inst. de Chim. des Substances N.
关键词
D O I
10.1016/S0957-4166(96)00453-3
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
New C-2 symmetrical imidazolium ribonucleosides have been synthesized. The silyl Hilbert Johnson-Vorbrugen method was used. Subsequent coupling of trimethylsilylimidazole with the peracylated D-ribofuranose 1, followed by removal of the protecting groups, afforded 1,3-bis(beta-D-ribofuranosyl)imidazolium 7 and 1-(beta-D-ribofuranosyl)imidazole 8. In a similar synthetic sequence, 4(5)-substituted bis-ribofuranosylimidazolium 14 was also prepared, For the selective preparation of the monoglycosylated imidazole 15, the classical method starting from 2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide in acetonitrile and using Hg(CN)2 was employed. These new base modified nucleosides were devoid of activity against HIV and cytotoxicity. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:3455 / 3464
页数:10
相关论文
共 19 条
[1]   EXPERIMENTS ON THE SYNTHESIS OF PURINE NUCLEOSIDES .19. A SYNTHESIS OF ADENOSINE [J].
DAVOLL, J ;
LYTHGOE, B ;
TODD, AR .
JOURNAL OF THE CHEMICAL SOCIETY, 1948, (JUL) :967-969
[2]   AIDS-DRIVEN NUCLEOSIDE CHEMISTRY [J].
HURYN, DM ;
OKABE, M .
CHEMICAL REVIEWS, 1992, 92 (08) :1745-1768
[3]   MOLECULAR AND CRYSTAL-STRUCTURE OF N-(BETA-D-RIBOFURANOSYL)IMIDAZOLE [J].
JAMES, MNG ;
MATSUSHIMA, M .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 1973, 29 (APR15) :838-846
[4]  
JOEL R, 1994, J MED CHEM, V34, P2306
[5]   NEW DIPEPTIDE ISOSTERES USEFUL FOR THE INHIBITION OF HIV-1 PROTEASE [J].
KALDOR, SW ;
HAMMOND, M ;
DRESSMAN, BA ;
FRITZ, JE ;
CROWELL, TA ;
HERMANN, RA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (11) :1385-1390
[6]   SYNTHESIS OF SYMMETRICAL PSEUDOPEPTIDES AS POTENTIAL INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE [J].
LANGLOIS, M ;
QUINTARD, D ;
ABALAIN, C .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (09) :639-647
[7]  
LUKEVICS E, 1991, NUCL SYNTHESIS ORGAN
[8]   A NOVEL NONPEPTIDE HIV-1 PROTEASE INHIBITOR - ELUCIDATION OF THE BINDING MODE AND ITS APPLICATION IN THE DESIGN OF RELATED ANALOGS [J].
LUNNEY, EA ;
HAGEN, SE ;
DOMAGALA, JM ;
HUMBLET, C ;
KOSINSKI, J ;
TAIT, BD ;
WARMUS, JS ;
WILSON, M ;
FERGUSON, D ;
HUPE, D ;
TUMMINO, PJ ;
BALDWIN, ET ;
BHAT, TN ;
LIU, BS ;
ERICKSON, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (17) :2664-2677
[9]   PEPTOID MIMICS OF A C-2-SYMMETRICAL INHIBITOR OF THE HIV-1 PROTEASE [J].
MAZALEYRAT, JP ;
RAGE, I ;
MOUNA, AM ;
SAVRDA, J ;
WAKSELMAN, M ;
BOULAY, R ;
LELIEVRE, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (11) :1281-1284
[10]   CIRCULAR-DICHROISM STUDIES ON AZOLE NUCLEOSIDES - THE SOLUTION CONFORMATION OF 5-AMINO-1-BETA-D-RIBOFURANOSYLIMIDAZOLE-4-CARBOXAMIDE, BREDININ, PYRAZOFURIN, RIBAVIRIN, AND RELATED NUCLEOSIDES [J].
MILES, DW ;
REVANKAR, GR ;
ROBINS, RK .
JOURNAL OF PHYSICAL CHEMISTRY, 1983, 87 (13) :2444-2450